HMGCR and familial pancreatic carcinoma: Use of statins that inhibit HMG-CoA reductase mediated cholesterol synthesis has been associated with decreased human pancreatic cancer risk and reduction of pancreatic cancer development and cancer cell growth in pre-clinical studies [82,83].